Literature DB >> 31441567

A systematic review of predictive models for recurrence and mortality in patients with tongue cancer.

Antonio Palazón-Bru1, Emma Mares-García1, David López-Bru2, Enrique Mares-Arambul3, Vicente Francisco Gil-Guillén1, María Ángeles Carbonell-Torregrosa1,4.   

Abstract

INTRODUCTION: Predictive models must meet clinical/methodological standards to be used in clinical practice. However, no critique of those models relating to mortality/recurrence in tongue cancer has been done bearing in mind the accepted standards.
METHODS: We conducted a systematic review evaluating the methodology and clinical applicability of predictive models for mortality/recurrence in tongue cancer published in MEDLINE and Scopus. For each model, we analysed (domains of CHARMS, Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies) the following: source of data, participants, outcome to be predicted, candidate predictors, sample size, missing data, model development, model performance, model evaluation, results and interpretation and discussion.
RESULTS: We found two papers that included eight prediction models, neither of which adhered to the CHARMS recommendations.
CONCLUSION: Given the quality of tongue cancer models, new studies following current consensus are needed to develop predictive tools applicable in clinical practice.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  head and neck neoplasms; models; review literature as topic; statistical; tongue neoplasms

Mesh:

Year:  2019        PMID: 31441567     DOI: 10.1111/ecc.13157

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  2 in total

1.  A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer.

Authors:  Inger-Heidi Bjerkli; Elin Hadler-Olsen; Elisabeth Sivy Nginamau; Helene Laurvik; Tine M Søland; Daniela Elena Costea; Lars Uhlin-Hansen; Sonja E Steigen
Journal:  Virchows Arch       Date:  2020-06-30       Impact factor: 4.064

2.  Silencing of SPP1 Suppresses Progression of Tongue Cancer by Mediating the PI3K/Akt Signaling Pathway.

Authors:  Qiaoli Zhang; Lifeng Li; Yueli Lai; Tong Zhao
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.